These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 20492579
21. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice. Kögel B, Christoph T, Strassburger W, Friderichs E. Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189 [Abstract] [Full Text] [Related]
22. [Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain]. Tschirner M, Ritzdorf I, Brünjes R. MMW Fortschr Med; 2008 Sep 18; 150 Suppl 3():142-8. PubMed ID: 19025217 [Abstract] [Full Text] [Related]
23. Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study. Mercadante S, Porzio G, Ferrera P, Aielli F, Verna L, Tirelli W, Villari P, Casuccio A. Clin Ther; 2009 Oct 18; 31(10):2134-8. PubMed ID: 19922884 [Abstract] [Full Text] [Related]
24. Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects. La Vincente SF, White JM, Somogyi AA, Bochner F, Chapleo CB. Clin Pharmacol Ther; 2008 Jan 18; 83(1):144-52. PubMed ID: 17568402 [Abstract] [Full Text] [Related]
25. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study. Sittl R, Nuijten M, Nautrup BP. Clin Ther; 2005 Jul 18; 27(7):1022-31. PubMed ID: 16154481 [Abstract] [Full Text] [Related]
26. Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment. Franchi S, Panerai AE, Sacerdote P. Brain Behav Immun; 2007 Aug 18; 21(6):767-74. PubMed ID: 17291715 [Abstract] [Full Text] [Related]
28. Anti-nociceptive efficacy of carprofen, levomethadone and buprenorphine for pain relief in cats following major orthopaedic surgery. Möllenhoff A, Nolte I, Kramer S. J Vet Med A Physiol Pathol Clin Med; 2005 May 18; 52(4):186-98. PubMed ID: 15882404 [Abstract] [Full Text] [Related]
29. Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients. Freye E, Anderson-Hillemacher A, Ritzdorf I, Levy JV. Pain Pract; 2007 Jun 18; 7(2):123-9. PubMed ID: 17559481 [Abstract] [Full Text] [Related]
30. Buprenorphine TDS: the clinical development rationale and results. Radbruch L, Vielvoye-Kerkmeer A. Int J Clin Pract Suppl; 2003 Feb 18; (133):15-8; discussion 23-4. PubMed ID: 12665119 [Abstract] [Full Text] [Related]
31. [No potentiation of fentanyl by use of transdermal buprenorphine in patients undergoing fast-track anesthesia for open-heart surgery]. Freye E, Hartung E, Levy JV. Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb 18; 41(2):86-92. PubMed ID: 16493560 [Abstract] [Full Text] [Related]
32. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. Mercadante S, Ferrera P, Villari P, Casuccio A, Intravaia G, Mangione S. J Pain Symptom Manage; 2009 Apr 18; 37(4):632-41. PubMed ID: 19345298 [Abstract] [Full Text] [Related]
33. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study. Sittl R, Likar R, Nautrup BP. Clin Ther; 2005 Feb 18; 27(2):225-37. PubMed ID: 15811486 [Abstract] [Full Text] [Related]
34. Buprenorphine TDS: use in daily practice, benefits for patients. Radbruch L. Int J Clin Pract Suppl; 2003 Feb 18; (133):19-22; discussion 23-4. PubMed ID: 12665120 [Abstract] [Full Text] [Related]
35. Transdermal buprenorphine in chronic pain: indications and clinical experience. Kusnik S, Likar R, Sittl R. Expert Rev Clin Pharmacol; 2008 Nov 18; 1(6):729-36. PubMed ID: 24410602 [Abstract] [Full Text] [Related]
36. Transdermal buprenorphine in children with cancer-related pain. Attinà G, Ruggiero A, Maurizi P, Arlotta A, Chiaretti A, Riccardi R. Pediatr Blood Cancer; 2009 Jan 18; 52(1):125-7. PubMed ID: 18802942 [Abstract] [Full Text] [Related]
37. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia. Bujalska M, Malinowska E, Makulska-Nowak H, Gumułka SW. Pharmacology; 2008 Jan 18; 82(3):180-6. PubMed ID: 18701828 [Abstract] [Full Text] [Related]
38. Transdermal buprenorphine in pain management--experiences from clinical practice: Five case studies. Louis F. Int J Clin Pract; 2006 Oct 18; 60(10):1330-4. PubMed ID: 16981980 [Abstract] [Full Text] [Related]
39. Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine. Strain EC, Walsh SL, Bigelow GE. Psychopharmacology (Berl); 2002 Jan 18; 159(2):161-6. PubMed ID: 11862344 [Abstract] [Full Text] [Related]
40. Effects of transdermal buprenorphine on patients-reported outcomes in cancer patients: results from the Cancer Pain Outcome Research (CPOR) Study Group. Apolone G, Corli O, Negri E, Mangano S, Montanari M, Greco MT, Cancer Pain Outcome Research Study Group (CPOR SG) Investigators, Apolone G, Bertetto O, Caraceni A, Corli O, De Conno F, Labianca R, Maltoni M, Nicora Maria F, Torri V, Zucco F. Clin J Pain; 2009 Oct 18; 25(8):671-82. PubMed ID: 19920716 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]